 | • レポートコード：QY2207C3452 • 出版社/出版日：QYResearch / 2022年7月11日 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Multi User | ￥1,087,800 (USD7,350) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症のパンデミックにより、世界の薬物誘発性腎毒性治療の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に薬物誘発性腎毒性治療の世界市場のxxx％を占める「ステロイド療法」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「製薬＆バイオテクノロジー企業」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国の薬物誘発性腎毒性治療の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの薬物誘発性腎毒性治療市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの薬物誘発性腎毒性治療市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 薬物誘発性腎毒性治療のグローバル主要メーカーには、Roche Diagnostic Limited、Siemens Healthcare、Abbott Laboratories、Thermo Fisher Scientific、Agilent Technologies、Bio-Rad Laboratories、Aushon BioSystem、Epistem、G.E. Healthcare、Affymetrixなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 薬物誘発性腎毒性治療市場は、種類と用途によって区分されます。世界の薬物誘発性腎毒性治療市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 ステロイド療法、その他 【用途別セグメント】 製薬＆バイオテクノロジー企業、学術機関、研究機関、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 薬物誘発性腎毒性治療製品概要 - 種類別市場（ステロイド療法、その他） - 用途別市場（製薬＆バイオテクノロジー企業、学術機関、研究機関、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の薬物誘発性腎毒性治療販売量予測2017-2028 - 世界の薬物誘発性腎毒性治療売上予測2017-2028 - 薬物誘発性腎毒性治療の地域別販売量 - 薬物誘発性腎毒性治療の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別薬物誘発性腎毒性治療販売量 - 主要メーカー別薬物誘発性腎毒性治療売上 - 主要メーカー別薬物誘発性腎毒性治療価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（ステロイド療法、その他） - 薬物誘発性腎毒性治療の種類別販売量 - 薬物誘発性腎毒性治療の種類別売上 - 薬物誘発性腎毒性治療の種類別価格 ・用途別市場規模（製薬＆バイオテクノロジー企業、学術機関、研究機関、その他） - 薬物誘発性腎毒性治療の用途別販売量 - 薬物誘発性腎毒性治療の用途別売上 - 薬物誘発性腎毒性治療の用途別価格 ・北米市場 - 北米の薬物誘発性腎毒性治療市場規模（種類別、用途別） - 主要国別の薬物誘発性腎毒性治療市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの薬物誘発性腎毒性治療市場規模（種類別、用途別） - 主要国別の薬物誘発性腎毒性治療市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の薬物誘発性腎毒性治療市場規模（種類別、用途別） - 主要国別の薬物誘発性腎毒性治療市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の薬物誘発性腎毒性治療市場規模（種類別、用途別） - 主要国別の薬物誘発性腎毒性治療市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの薬物誘発性腎毒性治療市場規模（種類別、用途別） - 主要国別の薬物誘発性腎毒性治療市場規模（トルコ、サウジアラビア） ・企業情報 Roche Diagnostic Limited、Siemens Healthcare、Abbott Laboratories、Thermo Fisher Scientific、Agilent Technologies、Bio-Rad Laboratories、Aushon BioSystem、Epistem、G.E. Healthcare、Affymetrix ・産業チェーン及び販売チャネル分析 - 薬物誘発性腎毒性治療の産業チェーン分析 - 薬物誘発性腎毒性治療の原材料 - 薬物誘発性腎毒性治療の生産プロセス - 薬物誘発性腎毒性治療の販売及びマーケティング - 薬物誘発性腎毒性治療の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 薬物誘発性腎毒性治療の産業動向 - 薬物誘発性腎毒性治療のマーケットドライバー - 薬物誘発性腎毒性治療の課題 - 薬物誘発性腎毒性治療の阻害要因 ・主な調査結果 |
Market Analysis and Insights: Global Drug-induced Nephrotoxicity Treatment Market
The global Drug-induced Nephrotoxicity Treatment market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Steroid Therapy accounting for % of the Drug-induced Nephrotoxicity Treatment global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Pharmaceutical and Biotechnology Companies segment is altered to an % CAGR throughout this forecast period.
China Drug-induced Nephrotoxicity Treatment market size is valued at US$ million in 2021, while the North America and Europe Drug-induced Nephrotoxicity Treatment are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Drug-induced Nephrotoxicity Treatment landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Drug-induced Nephrotoxicity Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Drug-induced Nephrotoxicity Treatment market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Drug-induced Nephrotoxicity Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Drug-induced Nephrotoxicity Treatment market.
Global Drug-induced Nephrotoxicity Treatment Scope and Market Size
Drug-induced Nephrotoxicity Treatment market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Drug-induced Nephrotoxicity Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Steroid Therapy
Others
Segment by Application
Pharmaceutical and Biotechnology Companies
Academic Institutes
Research Organizations
Others
By Company
Roche Diagnostic Limited
Siemens Healthcare
Abbott Laboratories
Thermo Fisher Scientific
Agilent Technologies
Bio-Rad Laboratories
Aushon BioSystem
Epistem
G.E. Healthcare
Affymetrix
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug-induced Nephrotoxicity Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Steroid Therapy
1.2.3 Others
1.3 Market by Application
1.3.1 Global Drug-induced Nephrotoxicity Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Pharmaceutical and Biotechnology Companies
1.3.3 Academic Institutes
1.3.4 Research Organizations
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Drug-induced Nephrotoxicity Treatment Market Perspective (2017-2028)
2.2 Drug-induced Nephrotoxicity Treatment Growth Trends by Region
2.2.1 Drug-induced Nephrotoxicity Treatment Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Drug-induced Nephrotoxicity Treatment Historic Market Size by Region (2017-2022)
2.2.3 Drug-induced Nephrotoxicity Treatment Forecasted Market Size by Region (2023-2028)
2.3 Drug-induced Nephrotoxicity Treatment Market Dynamics
2.3.1 Drug-induced Nephrotoxicity Treatment Industry Trends
2.3.2 Drug-induced Nephrotoxicity Treatment Market Drivers
2.3.3 Drug-induced Nephrotoxicity Treatment Market Challenges
2.3.4 Drug-induced Nephrotoxicity Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drug-induced Nephrotoxicity Treatment Players by Revenue
3.1.1 Global Top Drug-induced Nephrotoxicity Treatment Players by Revenue (2017-2022)
3.1.2 Global Drug-induced Nephrotoxicity Treatment Revenue Market Share by Players (2017-2022)
3.2 Global Drug-induced Nephrotoxicity Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Drug-induced Nephrotoxicity Treatment Revenue
3.4 Global Drug-induced Nephrotoxicity Treatment Market Concentration Ratio
3.4.1 Global Drug-induced Nephrotoxicity Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug-induced Nephrotoxicity Treatment Revenue in 2021
3.5 Drug-induced Nephrotoxicity Treatment Key Players Head office and Area Served
3.6 Key Players Drug-induced Nephrotoxicity Treatment Product Solution and Service
3.7 Date of Enter into Drug-induced Nephrotoxicity Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug-induced Nephrotoxicity Treatment Breakdown Data by Type
4.1 Global Drug-induced Nephrotoxicity Treatment Historic Market Size by Type (2017-2022)
4.2 Global Drug-induced Nephrotoxicity Treatment Forecasted Market Size by Type (2023-2028)
5 Drug-induced Nephrotoxicity Treatment Breakdown Data by Application
5.1 Global Drug-induced Nephrotoxicity Treatment Historic Market Size by Application (2017-2022)
5.2 Global Drug-induced Nephrotoxicity Treatment Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Drug-induced Nephrotoxicity Treatment Market Size (2017-2028)
6.2 North America Drug-induced Nephrotoxicity Treatment Market Size by Type
6.2.1 North America Drug-induced Nephrotoxicity Treatment Market Size by Type (2017-2022)
6.2.2 North America Drug-induced Nephrotoxicity Treatment Market Size by Type (2023-2028)
6.2.3 North America Drug-induced Nephrotoxicity Treatment Market Share by Type (2017-2028)
6.3 North America Drug-induced Nephrotoxicity Treatment Market Size by Application
6.3.1 North America Drug-induced Nephrotoxicity Treatment Market Size by Application (2017-2022)
6.3.2 North America Drug-induced Nephrotoxicity Treatment Market Size by Application (2023-2028)
6.3.3 North America Drug-induced Nephrotoxicity Treatment Market Share by Application (2017-2028)
6.4 North America Drug-induced Nephrotoxicity Treatment Market Size by Country
6.4.1 North America Drug-induced Nephrotoxicity Treatment Market Size by Country (2017-2022)
6.4.2 North America Drug-induced Nephrotoxicity Treatment Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Drug-induced Nephrotoxicity Treatment Market Size (2017-2028)
7.2 Europe Drug-induced Nephrotoxicity Treatment Market Size by Type
7.2.1 Europe Drug-induced Nephrotoxicity Treatment Market Size by Type (2017-2022)
7.2.2 Europe Drug-induced Nephrotoxicity Treatment Market Size by Type (2023-2028)
7.2.3 Europe Drug-induced Nephrotoxicity Treatment Market Share by Type (2017-2028)
7.3 Europe Drug-induced Nephrotoxicity Treatment Market Size by Application
7.3.1 Europe Drug-induced Nephrotoxicity Treatment Market Size by Application (2017-2022)
7.3.2 Europe Drug-induced Nephrotoxicity Treatment Market Size by Application (2023-2028)
7.3.3 Europe Drug-induced Nephrotoxicity Treatment Market Share by Application (2017-2028)
7.4 Europe Drug-induced Nephrotoxicity Treatment Market Size by Country
7.4.1 Europe Drug-induced Nephrotoxicity Treatment Market Size by Country (2017-2022)
7.4.2 Europe Drug-induced Nephrotoxicity Treatment Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drug-induced Nephrotoxicity Treatment Market Size (2017-2028)
8.2 Asia-Pacific Drug-induced Nephrotoxicity Treatment Market Size by Type
8.2.1 Asia-Pacific Drug-induced Nephrotoxicity Treatment Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Drug-induced Nephrotoxicity Treatment Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Drug-induced Nephrotoxicity Treatment Market Share by Type (2017-2028)
8.3 Asia-Pacific Drug-induced Nephrotoxicity Treatment Market Size by Application
8.3.1 Asia-Pacific Drug-induced Nephrotoxicity Treatment Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Drug-induced Nephrotoxicity Treatment Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Drug-induced Nephrotoxicity Treatment Market Share by Application (2017-2028)
8.4 Asia-Pacific Drug-induced Nephrotoxicity Treatment Market Size by Region
8.4.1 Asia-Pacific Drug-induced Nephrotoxicity Treatment Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Drug-induced Nephrotoxicity Treatment Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Drug-induced Nephrotoxicity Treatment Market Size (2017-2028)
9.2 Latin America Drug-induced Nephrotoxicity Treatment Market Size by Type
9.2.1 Latin America Drug-induced Nephrotoxicity Treatment Market Size by Type (2017-2022)
9.2.2 Latin America Drug-induced Nephrotoxicity Treatment Market Size by Type (2023-2028)
9.2.3 Latin America Drug-induced Nephrotoxicity Treatment Market Share by Type (2017-2028)
9.3 Latin America Drug-induced Nephrotoxicity Treatment Market Size by Application
9.3.1 Latin America Drug-induced Nephrotoxicity Treatment Market Size by Application (2017-2022)
9.3.2 Latin America Drug-induced Nephrotoxicity Treatment Market Size by Application (2023-2028)
9.3.3 Latin America Drug-induced Nephrotoxicity Treatment Market Share by Application (2017-2028)
9.4 Latin America Drug-induced Nephrotoxicity Treatment Market Size by Country
9.4.1 Latin America Drug-induced Nephrotoxicity Treatment Market Size by Country (2017-2022)
9.4.2 Latin America Drug-induced Nephrotoxicity Treatment Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drug-induced Nephrotoxicity Treatment Market Size (2017-2028)
10.2 Middle East & Africa Drug-induced Nephrotoxicity Treatment Market Size by Type
10.2.1 Middle East & Africa Drug-induced Nephrotoxicity Treatment Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Drug-induced Nephrotoxicity Treatment Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Drug-induced Nephrotoxicity Treatment Market Share by Type (2017-2028)
10.3 Middle East & Africa Drug-induced Nephrotoxicity Treatment Market Size by Application
10.3.1 Middle East & Africa Drug-induced Nephrotoxicity Treatment Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Drug-induced Nephrotoxicity Treatment Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Drug-induced Nephrotoxicity Treatment Market Share by Application (2017-2028)
10.4 Middle East & Africa Drug-induced Nephrotoxicity Treatment Market Size by Country
10.4.1 Middle East & Africa Drug-induced Nephrotoxicity Treatment Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Drug-induced Nephrotoxicity Treatment Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Roche Diagnostic Limited
11.1.1 Roche Diagnostic Limited Company Details
11.1.2 Roche Diagnostic Limited Business Overview
11.1.3 Roche Diagnostic Limited Drug-induced Nephrotoxicity Treatment Introduction
11.1.4 Roche Diagnostic Limited Revenue in Drug-induced Nephrotoxicity Treatment Business (2017-2022)
11.1.5 Roche Diagnostic Limited Recent Developments
11.2 Siemens Healthcare
11.2.1 Siemens Healthcare Company Details
11.2.2 Siemens Healthcare Business Overview
11.2.3 Siemens Healthcare Drug-induced Nephrotoxicity Treatment Introduction
11.2.4 Siemens Healthcare Revenue in Drug-induced Nephrotoxicity Treatment Business (2017-2022)
11.2.5 Siemens Healthcare Recent Developments
11.3 Abbott Laboratories
11.3.1 Abbott Laboratories Company Details
11.3.2 Abbott Laboratories Business Overview
11.3.3 Abbott Laboratories Drug-induced Nephrotoxicity Treatment Introduction
11.3.4 Abbott Laboratories Revenue in Drug-induced Nephrotoxicity Treatment Business (2017-2022)
11.3.5 Abbott Laboratories Recent Developments
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Details
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Drug-induced Nephrotoxicity Treatment Introduction
11.4.4 Thermo Fisher Scientific Revenue in Drug-induced Nephrotoxicity Treatment Business (2017-2022)
11.4.5 Thermo Fisher Scientific Recent Developments
11.5 Agilent Technologies
11.5.1 Agilent Technologies Company Details
11.5.2 Agilent Technologies Business Overview
11.5.3 Agilent Technologies Drug-induced Nephrotoxicity Treatment Introduction
11.5.4 Agilent Technologies Revenue in Drug-induced Nephrotoxicity Treatment Business (2017-2022)
11.5.5 Agilent Technologies Recent Developments
11.6 Bio-Rad Laboratories
11.6.1 Bio-Rad Laboratories Company Details
11.6.2 Bio-Rad Laboratories Business Overview
11.6.3 Bio-Rad Laboratories Drug-induced Nephrotoxicity Treatment Introduction
11.6.4 Bio-Rad Laboratories Revenue in Drug-induced Nephrotoxicity Treatment Business (2017-2022)
11.6.5 Bio-Rad Laboratories Recent Developments
11.7 Aushon BioSystem
11.7.1 Aushon BioSystem Company Details
11.7.2 Aushon BioSystem Business Overview
11.7.3 Aushon BioSystem Drug-induced Nephrotoxicity Treatment Introduction
11.7.4 Aushon BioSystem Revenue in Drug-induced Nephrotoxicity Treatment Business (2017-2022)
11.7.5 Aushon BioSystem Recent Developments
11.8 Epistem
11.8.1 Epistem Company Details
11.8.2 Epistem Business Overview
11.8.3 Epistem Drug-induced Nephrotoxicity Treatment Introduction
11.8.4 Epistem Revenue in Drug-induced Nephrotoxicity Treatment Business (2017-2022)
11.8.5 Epistem Recent Developments
11.9 G.E. Healthcare
11.9.1 G.E. Healthcare Company Details
11.9.2 G.E. Healthcare Business Overview
11.9.3 G.E. Healthcare Drug-induced Nephrotoxicity Treatment Introduction
11.9.4 G.E. Healthcare Revenue in Drug-induced Nephrotoxicity Treatment Business (2017-2022)
11.9.5 G.E. Healthcare Recent Developments
11.10 Affymetrix
11.10.1 Affymetrix Company Details
11.10.2 Affymetrix Business Overview
11.10.3 Affymetrix Drug-induced Nephrotoxicity Treatment Introduction
11.10.4 Affymetrix Revenue in Drug-induced Nephrotoxicity Treatment Business (2017-2022)
11.10.5 Affymetrix Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
Table 1. Global Drug-induced Nephrotoxicity Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Steroid Therapy
Table 3. Key Players of Others
Table 4. Global Drug-induced Nephrotoxicity Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Drug-induced Nephrotoxicity Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Drug-induced Nephrotoxicity Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Drug-induced Nephrotoxicity Treatment Market Share by Region (2017-2022)
Table 8. Global Drug-induced Nephrotoxicity Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Drug-induced Nephrotoxicity Treatment Market Share by Region (2023-2028)
Table 10. Drug-induced Nephrotoxicity Treatment Market Trends
Table 11. Drug-induced Nephrotoxicity Treatment Market Drivers
Table 12. Drug-induced Nephrotoxicity Treatment Market Challenges
Table 13. Drug-induced Nephrotoxicity Treatment Market Restraints
Table 14. Global Drug-induced Nephrotoxicity Treatment Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Drug-induced Nephrotoxicity Treatment Revenue Share by Players (2017-2022)
Table 16. Global Top Drug-induced Nephrotoxicity Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug-induced Nephrotoxicity Treatment as of 2021)
Table 17. Ranking of Global Top Drug-induced Nephrotoxicity Treatment Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Drug-induced Nephrotoxicity Treatment Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Drug-induced Nephrotoxicity Treatment Product Solution and Service
Table 21. Date of Enter into Drug-induced Nephrotoxicity Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Drug-induced Nephrotoxicity Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Drug-induced Nephrotoxicity Treatment Revenue Market Share by Type (2017-2022)
Table 25. Global Drug-induced Nephrotoxicity Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Drug-induced Nephrotoxicity Treatment Revenue Market Share by Type (2023-2028)
Table 27. Global Drug-induced Nephrotoxicity Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Drug-induced Nephrotoxicity Treatment Revenue Share by Application (2017-2022)
Table 29. Global Drug-induced Nephrotoxicity Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Drug-induced Nephrotoxicity Treatment Revenue Share by Application (2023-2028)
Table 31. North America Drug-induced Nephrotoxicity Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America Drug-induced Nephrotoxicity Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America Drug-induced Nephrotoxicity Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 34. North America Drug-induced Nephrotoxicity Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 35. North America Drug-induced Nephrotoxicity Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America Drug-induced Nephrotoxicity Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe Drug-induced Nephrotoxicity Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe Drug-induced Nephrotoxicity Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe Drug-induced Nephrotoxicity Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 40. Europe Drug-induced Nephrotoxicity Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 41. Europe Drug-induced Nephrotoxicity Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe Drug-induced Nephrotoxicity Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific Drug-induced Nephrotoxicity Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Drug-induced Nephrotoxicity Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Drug-induced Nephrotoxicity Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific Drug-induced Nephrotoxicity Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific Drug-induced Nephrotoxicity Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Drug-induced Nephrotoxicity Treatment Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America Drug-induced Nephrotoxicity Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America Drug-induced Nephrotoxicity Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America Drug-induced Nephrotoxicity Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 52. Latin America Drug-induced Nephrotoxicity Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 53. Latin America Drug-induced Nephrotoxicity Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America Drug-induced Nephrotoxicity Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Drug-induced Nephrotoxicity Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Drug-induced Nephrotoxicity Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Drug-induced Nephrotoxicity Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Drug-induced Nephrotoxicity Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Drug-induced Nephrotoxicity Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Drug-induced Nephrotoxicity Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 61. Roche Diagnostic Limited Company Details
Table 62. Roche Diagnostic Limited Business Overview
Table 63. Roche Diagnostic Limited Drug-induced Nephrotoxicity Treatment Product
Table 64. Roche Diagnostic Limited Revenue in Drug-induced Nephrotoxicity Treatment Business (2017-2022) & (US$ Million)
Table 65. Roche Diagnostic Limited Recent Developments
Table 66. Siemens Healthcare Company Details
Table 67. Siemens Healthcare Business Overview
Table 68. Siemens Healthcare Drug-induced Nephrotoxicity Treatment Product
Table 69. Siemens Healthcare Revenue in Drug-induced Nephrotoxicity Treatment Business (2017-2022) & (US$ Million)
Table 70. Siemens Healthcare Recent Developments
Table 71. Abbott Laboratories Company Details
Table 72. Abbott Laboratories Business Overview
Table 73. Abbott Laboratories Drug-induced Nephrotoxicity Treatment Product
Table 74. Abbott Laboratories Revenue in Drug-induced Nephrotoxicity Treatment Business (2017-2022) & (US$ Million)
Table 75. Abbott Laboratories Recent Developments
Table 76. Thermo Fisher Scientific Company Details
Table 77. Thermo Fisher Scientific Business Overview
Table 78. Thermo Fisher Scientific Drug-induced Nephrotoxicity Treatment Product
Table 79. Thermo Fisher Scientific Revenue in Drug-induced Nephrotoxicity Treatment Business (2017-2022) & (US$ Million)
Table 80. Thermo Fisher Scientific Recent Developments
Table 81. Agilent Technologies Company Details
Table 82. Agilent Technologies Business Overview
Table 83. Agilent Technologies Drug-induced Nephrotoxicity Treatment Product
Table 84. Agilent Technologies Revenue in Drug-induced Nephrotoxicity Treatment Business (2017-2022) & (US$ Million)
Table 85. Agilent Technologies Recent Developments
Table 86. Bio-Rad Laboratories Company Details
Table 87. Bio-Rad Laboratories Business Overview
Table 88. Bio-Rad Laboratories Drug-induced Nephrotoxicity Treatment Product
Table 89. Bio-Rad Laboratories Revenue in Drug-induced Nephrotoxicity Treatment Business (2017-2022) & (US$ Million)
Table 90. Bio-Rad Laboratories Recent Developments
Table 91. Aushon BioSystem Company Details
Table 92. Aushon BioSystem Business Overview
Table 93. Aushon BioSystem Drug-induced Nephrotoxicity Treatment Product
Table 94. Aushon BioSystem Revenue in Drug-induced Nephrotoxicity Treatment Business (2017-2022) & (US$ Million)
Table 95. Aushon BioSystem Recent Developments
Table 96. Epistem Company Details
Table 97. Epistem Business Overview
Table 98. Epistem Drug-induced Nephrotoxicity Treatment Product
Table 99. Epistem Revenue in Drug-induced Nephrotoxicity Treatment Business (2017-2022) & (US$ Million)
Table 100. Epistem Recent Developments
Table 101. G.E. Healthcare Company Details
Table 102. G.E. Healthcare Business Overview
Table 103. G.E. Healthcare Drug-induced Nephrotoxicity Treatment Product
Table 104. G.E. Healthcare Revenue in Drug-induced Nephrotoxicity Treatment Business (2017-2022) & (US$ Million)
Table 105. G.E. Healthcare Recent Developments
Table 106. Affymetrix Company Details
Table 107. Affymetrix Business Overview
Table 108. Affymetrix Drug-induced Nephrotoxicity Treatment Product
Table 109. Affymetrix Revenue in Drug-induced Nephrotoxicity Treatment Business (2017-2022) & (US$ Million)
Table 110. Affymetrix Recent Developments
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Drug-induced Nephrotoxicity Treatment Market Share by Type: 2021 VS 2028
Figure 2. Steroid Therapy Features
Figure 3. Others Features
Figure 4. Global Drug-induced Nephrotoxicity Treatment Market Share by Application: 2021 VS 2028
Figure 5. Pharmaceutical and Biotechnology Companies Case Studies
Figure 6. Academic Institutes Case Studies
Figure 7. Research Organizations Case Studies
Figure 8. Others Case Studies
Figure 9. Drug-induced Nephrotoxicity Treatment Report Years Considered
Figure 10. Global Drug-induced Nephrotoxicity Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 11. Global Drug-induced Nephrotoxicity Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Drug-induced Nephrotoxicity Treatment Market Share by Region: 2021 VS 2028
Figure 13. Global Drug-induced Nephrotoxicity Treatment Market Share by Players in 2021
Figure 14. Global Top Drug-induced Nephrotoxicity Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug-induced Nephrotoxicity Treatment as of 2021)
Figure 15. The Top 10 and 5 Players Market Share by Drug-induced Nephrotoxicity Treatment Revenue in 2021
Figure 16. North America Drug-induced Nephrotoxicity Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 17. North America Drug-induced Nephrotoxicity Treatment Market Size Market Share by Type (2017-2028)
Figure 18. North America Drug-induced Nephrotoxicity Treatment Market Size Market Share by Application (2017-2028)
Figure 19. North America Drug-induced Nephrotoxicity Treatment Market Size Share by Country (2017-2028)
Figure 20. United States Drug-induced Nephrotoxicity Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Canada Drug-induced Nephrotoxicity Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Drug-induced Nephrotoxicity Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 23. Europe Drug-induced Nephrotoxicity Treatment Market Size Market Share by Type (2017-2028)
Figure 24. Europe Drug-induced Nephrotoxicity Treatment Market Size Market Share by Application (2017-2028)
Figure 25. Europe Drug-induced Nephrotoxicity Treatment Market Size Share by Country (2017-2028)
Figure 26. Germany Drug-induced Nephrotoxicity Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. France Drug-induced Nephrotoxicity Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. U.K. Drug-induced Nephrotoxicity Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Italy Drug-induced Nephrotoxicity Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Russia Drug-induced Nephrotoxicity Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Nordic Countries Drug-induced Nephrotoxicity Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Asia-Pacific Drug-induced Nephrotoxicity Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 33. Asia Pacific Drug-induced Nephrotoxicity Treatment Market Size Market Share by Type (2017-2028)
Figure 34. Asia Pacific Drug-induced Nephrotoxicity Treatment Market Size Market Share by Application (2017-2028)
Figure 35. Asia Pacific Drug-induced Nephrotoxicity Treatment Market Size Share by Region (2017-2028)
Figure 36. China Drug-induced Nephrotoxicity Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Japan Drug-induced Nephrotoxicity Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. South Korea Drug-induced Nephrotoxicity Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Southeast Asia Drug-induced Nephrotoxicity Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. India Drug-induced Nephrotoxicity Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Australia Drug-induced Nephrotoxicity Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 42. Latin America Drug-induced Nephrotoxicity Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 43. Latin America Drug-induced Nephrotoxicity Treatment Market Size Market Share by Type (2017-2028)
Figure 44. Latin America Drug-induced Nephrotoxicity Treatment Market Size Market Share by Application (2017-2028)
Figure 45. Latin America Drug-induced Nephrotoxicity Treatment Market Size Share by Country (2017-2028)
Figure 46. Mexico Drug-induced Nephrotoxicity Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Brazil Drug-induced Nephrotoxicity Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Middle East & Africa Drug-induced Nephrotoxicity Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 49. Middle East and Africa Drug-induced Nephrotoxicity Treatment Market Size Market Share by Type (2017-2028)
Figure 50. Middle East and Africa Drug-induced Nephrotoxicity Treatment Market Size Market Share by Application (2017-2028)
Figure 51. Middle East and Africa Drug-induced Nephrotoxicity Treatment Market Size Share by Country (2017-2028)
Figure 52. Turkey Drug-induced Nephrotoxicity Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Saudi Arabia Drug-induced Nephrotoxicity Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. UAE Drug-induced Nephrotoxicity Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Roche Diagnostic Limited Revenue Growth Rate in Drug-induced Nephrotoxicity Treatment Business (2017-2022)
Figure 56. Siemens Healthcare Revenue Growth Rate in Drug-induced Nephrotoxicity Treatment Business (2017-2022)
Figure 57. Abbott Laboratories Revenue Growth Rate in Drug-induced Nephrotoxicity Treatment Business (2017-2022)
Figure 58. Thermo Fisher Scientific Revenue Growth Rate in Drug-induced Nephrotoxicity Treatment Business (2017-2022)
Figure 59. Agilent Technologies Revenue Growth Rate in Drug-induced Nephrotoxicity Treatment Business (2017-2022)
Figure 60. Bio-Rad Laboratories Revenue Growth Rate in Drug-induced Nephrotoxicity Treatment Business (2017-2022)
Figure 61. Aushon BioSystem Revenue Growth Rate in Drug-induced Nephrotoxicity Treatment Business (2017-2022)
Figure 62. Epistem Revenue Growth Rate in Drug-induced Nephrotoxicity Treatment Business (2017-2022)
Figure 63. G.E. Healthcare Revenue Growth Rate in Drug-induced Nephrotoxicity Treatment Business (2017-2022)
Figure 64. Affymetrix Revenue Growth Rate in Drug-induced Nephrotoxicity Treatment Business (2017-2022)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed